ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals Inc (RXRX)

7.49
0.61
(8.87%)
Cerrado 22 Enero 3:00PM
7.4298
-0.0602
(-0.80%)
Fuera de horario: 6:59PM

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

RXRX Noticias

Solo noticias oficiales

RXRX Discussion

Ver más
bwrbad bwrbad 24 horas hace
promised to accumulate 10k shares before Q end and hold for years. predict this issue never go BK, do RS, and one day go beyond 200+ like established big cap security issues.
👍️0
bwrbad bwrbad 3 días hace
bandwagon
👍️0
bwrbad bwrbad 1 semana hace
believe in miracle ----- come to RXRX------
👍️0
TucsonPhil TucsonPhil 2 semanas hace
Looks like Lilly is late to the party.

https://www.statnews.com/2025/01/10/eli-lilly-andreessen-horowitz-500-million-venture-fund-ai-focus/
👍️0
bwrbad bwrbad 2 semanas hace
cursion-re-cursion in flame after FDA REC 3565 blessings
👍️0
bwrbad bwrbad 2 semanas hace
Gibson🤢🥵🥶😷Gibson
👍️0
bwrbad bwrbad 3 semanas hace
baby nvda
👍 1
bwrbad bwrbad 3 semanas hace
balding haircut at RXRX
👍️0
Monksdream Monksdream 1 mes hace
RXRX, under $7
👍️0
bwrbad bwrbad 1 mes hace
out for now, let CEO work his magic if he has one under his sleeve
👍️0
bwrbad bwrbad 1 mes hace
is something wrong with RxRx, it looked promising based on what said to public. but something not right. ground shaken up. - like trouble.
what wrong with the CEO. if this continues that is bad sign for future of the company and the CEO.
👍️0
bwrbad bwrbad 1 mes hace
RXRX
👍️0
bwrbad bwrbad 1 mes hace
RxRx partnership: GOOG NVDA MSFT Roche/Genentech Bayer Bristol Myers Squibb Sanofi Merck ......
👍 1
bwrbad bwrbad 1 mes hace
RxRx M&A: Valence –Cyclica - Exscientia
Valence – a leader in generative AI and deep learning models
Cyclica - a deep learning engine that predicts the polypharmacology of small molecules in drug discovery.
Exscientia - AI-driven precision medicine
RXRX - Regenerative AI - TechBio powerhouse
undergoing post merger reorganization, some job cuts
enough cash to fund through 2027
Ark Q3 2024 Stake: $215.9 million
Hedge Fund Investors Q3 2024:: 16
more than ten drugs in trials.
👍️0
bwrbad bwrbad 1 mes hace
market up big and RxRx ignored,
if quantum computing which is 7-10 years away getting attention now, then this should be in the rocket heading for stratosphere.
👍️0
TucsonPhil TucsonPhil 1 mes hace
RXRX seeing some promising results in early trials. Proof of concept will solidify belief in the platform.

If cost of trials can be reduced, by less attrition of candidates, then they should see more licensing agreements, and funding, from pharma companies IMO.
👍️ 1
bwrbad bwrbad 1 mes hace
Revenue (ttm) 65.18M; Quarterly Revenue Growth (yoy) 147.60%
Total Cash (mrq) 427.65M; Total Debt (mrq) 90.62M
Shares Outstanding 6 388.94M; Float 8 252.42M
clinical trial : REC-994 in Phase 2, REC-2282 in Phase 2/3; few other in phase 1 and 2, all in less than 2 year not 15-18 years (conventional).

% Held by Institutions 1 69.40% Shares Short (Nov 15, 2024) 4 64.57M 25%
👍️ 1
JJ8 JJ8 1 mes hace
Rxrx share price Long Tail Up since 06 Dec 2024.
👍️0
paperman paperman 1 mes hace
Phase 1 news expected tonight at conference.
👍️0
paperman paperman 1 mes hace
Phase 1 news expected tonight at conference.
👍️0
bwrbad bwrbad 1 mes hace
this is one magnificent AI drug discovery platform - be household name like google tesla Microsoft ...
👍️0
JJ8 JJ8 2 meses hace
Bought it yesterday at $6.60

Today it's up about 22%.

Same story with 2 other stocks and they all go up today more than 20%!

Whoa! IN CREDIBLE!
👍️0
TucsonPhil TucsonPhil 2 meses hace
Agreed, but there will be wild swings, until they get their footing with clinical trials proving the concept works. Trade it until then, and keep one foot in the door for surprise announcements.
👍️0
bwrbad bwrbad 2 meses hace
RxRx going to be top player in future pharma drug discovery
👍️0
TucsonPhil TucsonPhil 2 meses hace
Good company, but MMs playing games this morning. Insider buying? News? Who knows? Missed this runup, but will wait for the dip again.
👍️0
bwrbad bwrbad 2 meses hace
GOOG -- RxRx -- NVDA -- RxRx -- MSFT
👍️0
bwrbad bwrbad 2 meses hace
agree but better, much bigger scope, on way to become a high flying company of the future
price target 150 in two year
👍️0
uksausage uksausage 2 meses hace
no it is the PLTR of Drug discovery
both rely on NVDA to run fast
👍️0
bwrbad bwrbad 2 meses hace
started buying little little- this is NVDA of DRUG DISCOVERY
👍️0
ToucanYoucan ToucanYoucan 2 meses hace
$RXRX - That's why I'm planning to steadily accumulate shares - with the hope that one or more of these new treatments materializes.
👍️0
bwrbad bwrbad 2 meses hace
high potential if delivers,
👍️0
TucsonPhil TucsonPhil 2 meses hace
Good gains in past week, but looks like it is getting ready to drift lower again.
👍️0
TucsonPhil TucsonPhil 2 meses hace
First patient dosed.

https://ir.recursion.com/news-releases/news-release-details/recursion-announces-first-patient-dosed-phase-12-clinical-study
👍️0
lambchops lambchops 2 meses hace
Glad to see the uptick! Was beaten down for a while. Too good of stock to be down for long.

LC

RXRX
👍️ 1
ToucanYoucan ToucanYoucan 2 meses hace
$RXRX - Having a huge day here!!
👍️0
ToucanYoucan ToucanYoucan 2 meses hace
$RXRX - Nice move up today! This will take a little time to find its footing pps-wise after the merger...imo
👍️0
TucsonPhil TucsonPhil 2 meses hace
Many foreign countries supplying pharmaceuticals to U.S. at exorbitant markups.

Will anything be done about that? I do not believe tariffs will help with that problem, since people either pay, whatever the cost, or suffer and die.
👍️0
Monksdream Monksdream 3 meses hace
RXRX 10Q 11/6
👍️0
Monksdream Monksdream 3 meses hace
RXRX under $10
👍️0
Monksdream Monksdream 3 meses hace
RXRX under $10
👍️0
mick mick 3 meses hace
👍️0
abrooklyn abrooklyn 4 meses hace
https://x.com/RecursionPharma/status/1841453309342740925
👍️0
TucsonPhil TucsonPhil 4 meses hace
So many clinical trials in work, but for this to translate to value, they will need to show high efficacy and a much shorter time-to-market, using Recursion platform. The problem may be that Recursion can identify promising candidates quickly, but the slow-moving follow-on processes will still eat up valuable time. The value proposition here is the decrease in attrition, for candidates that fail in early stage trials.

https://ir.recursion.com/news-releases/news-release-details/recursion-gives-guidance-seven-clinical-readouts-within-18

https://www.recursion.com/pipeline
👍️0
mick mick 4 meses hace
WALL @ $7.5 , $7.0
👍️0
mick mick 4 meses hace
https://www.stockscores.com/charts/charts/?ticker=RXRX
👍️0
lambchops lambchops 4 meses hace
Yes. Good stock to put on watchlist IMO.
Still reasonably cheap. Check MACD.

LC

RXRX
👍️0
mick mick 4 meses hace
diamond in the ruff

RXRX
Recursion Pharmaceuticals Inc
6.32
0.20 (3.27%)
Volume: 3,082,418
Day Range: 6.055 - 6.32
Last Trade Time: 4:28:47 PM EDT
👍️0
mick mick 5 meses hace
RXRX
Recursion Pharmaceuticals Inc
5.95
-0.22 (-3.57%)
Volume: 4,577,882
Day Range: 5.895 - 6.30
Last Trade Time: 7:58:59 PM EDT
👍️0
lambchops lambchops 5 meses hace
Yes, I've been adding shares of RXRX this week.

LC

RXRX
👍️0
TucsonPhil TucsonPhil 5 meses hace
Looks.like a little dilution, but a good buying opportunity, to add some more.
👍️0

Su Consulta Reciente

Delayed Upgrade Clock